Mira Pharmaceuticals, Inc.
MIRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001904286
No open-market purchases or sales by Mira Pharmaceuticals, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $2.19M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Mira Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 11 | 11 | 0 |
| Shares | 640.9K | 711.9K | +71.0K (+11.1%) |
| Value | $704.0K | $454.0K | −$250.0K (−35.5%) |
New holders (4)
Institutions that held Mira Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Avantax Planning Partners, Inc. | 118,751 | $75.6K | 0.00% |
| Citadel Advisors LLC | 24,396 | $16.1K | 0.00% |
| Bank of New York Mellon Corp | 20,001 | $12.7K | 0.00% |
| Two Sigma Securities, LLC | 17,869 | $11.4K | 0.00% |
Sold out (4)
Institutions that held Mira Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Virtu Financial LLC | 63,055 | $69.0K |
| HRT Financial LP | 30,651 | $33.0K |
| XTX Topco Ltd | 25,544 | $28.1K |
| Susquehanna International Group, LLP | 15,573 | $17.1K |